Phase II study of intensive CEV (Carboplatin, Epirubicin and VP-16) Plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancer

C. Gridelli, F. Perrone, M. D'Aprile, A. Rossi, S. Palmeri, C. Curcio, E. Veltri, G. Ianniello, V. Lorusso, G. Palmieri, L. Rinaldi, S. De Placido, C. Gallo

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)2424-2426
Number of pages3
JournalEuropean Journal of Cancer
Volume31
Issue number13-14
DOIs
Publication statusPublished - 1995

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Hematology

Cite this

Gridelli, C., Perrone, F., D'Aprile, M., Rossi, A., Palmeri, S., Curcio, C., Veltri, E., Ianniello, G., Lorusso, V., Palmieri, G., Rinaldi, L., De Placido, S., & Gallo, C. (1995). Phase II study of intensive CEV (Carboplatin, Epirubicin and VP-16) Plus G-CSF (granulocyte-colony stimulating factor) in extensive small cell lung cancer. European Journal of Cancer, 31(13-14), 2424-2426. https://doi.org/10.1016/0959-8049(95)00403-3